NCT01228071 - Time to Eugonadal Range, Time to Steady State and Drying Time | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Male Hypogonadism

Interventions

DRUG

testosterone gel 2%

40 mg testosterone gel 2%

Trial Locations (8)

Matrix Research, LLC, Greer

Southeastern Research Group, Inc., Tallahassee

Compass Research East, LLC, Oviedo

Tory Internal Medicine, PC, Troy

Cetero Research, San Antonio

Quality of Life Medical & Research Center, Tucson

Connecticut Clinical Research, Middlebury

Men's Health Boston, Brookline